Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Decreased total B cell count, Bone marrow hypocellularity, Immunodeficiency, and Reduced total natural killer cell count; and common findings: Inflammation of the large intestine, Delayed speech and language development, Esophageal stricture, and Pancolitis and others. 18 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 3 | Oral leukoplakia, Low blood cell counts (all types) (pancytopenia), Immunodeficiency |
DCLRE1B encodes DNA cross-link repair 1B (532 aa). 5'-3' exonuclease that plays a central role in telomere maintenance and protection during S-phase. Highest expression in Cells Cultured fibroblasts (12.9 TPM) and Cells EBV-transformed lymphocytes (10.9 TPM).
Dyskeratosis congenita, autosomal recessive 8 is associated with mutations in the DCLRE1B gene on chromosome 1.
The DCLRE1B protein participates in DNA nucleases unhook the interstrand crosslink (ICL) pathway.
DCLRE1B is classified as a druggable target with score 0.0.
Genetic testing for DCLRE1B is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features, 12 common features.
No clinical trials have been registered for dyskeratosis congenita, autosomal recessive 8.
6 publications have been identified in PubMed for dyskeratosis congenita, autosomal recessive 8. Research spans Review / Meta-Analysis (50%) and Epidemiology / Natural History (50%).
Niknafs AM (2026). [PMID: 40762130](https://pubmed.ncbi.nlm.nih.gov/40762130/). *Clin Genet*. [Epidemiology / Natural History]
Tometten M (2025). [PMID: 39938003](https://pubmed.ncbi.nlm.nih.gov/39938003/). *Blood Adv*. [Epidemiology / Natural History]
Nakano Y (2024). [PMID: 39264246](https://pubmed.ncbi.nlm.nih.gov/39264246/). *Clin Cancer Res*. [Review / Meta-Analysis]
Niewisch MR (2024). [PMID: 39661387](https://pubmed.ncbi.nlm.nih.gov/39661387/). *JAMA Netw Open*. [Epidemiology / Natural History]
Rolles B (2024). [PMID: 39371255](https://pubmed.ncbi.nlm.nih.gov/39371255/). *Transfus Med Hemother*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:12 PM UTC
Online Mendelian Inheritance in Man
Digestive system | 2 | Inflammation of the large intestine, Esophageal stricture |
Brain and nerves | 1 | Delayed speech and language development |
Muscles | 1 | Shrinkage of the cerebellum (cerebellar atrophy) |
Bones and joints | 1 | Bone marrow hypocellularity |
Growth and development | 1 | Intrauterine growth retardation |
Skin | 1 | Nail dystrophy |